首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of addiction medicine

缩写:J ADDICT MED

ISSN:1932-0620

e-ISSN:1935-3227

IF/分区:3.1/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1848
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Sonia Hernandez-Diaz,Krista F Huybrechts Sonia Hernandez-Diaz
The increased availability of fentanyl in the United States over the past decade extends to women of reproductive age, raising concern about maternal and fetal risks when used in pregnancy. A 2023 case series of 10 infants exposed to fentan...
Fares Qeadan,Rose Thornquist,Benjamin Tingey Fares Qeadan
Objectives: Illness severity may influence the relationship between opioid use disorder (OUD) and adverse outcomes, yet factors affecting severity are not fully understood. The objective of this study is to examine sociod...
Symphanie Key,Megan E Mansfield,Edward C Traver et al. Symphanie Key et al.
Objectives: People who inject drugs (PWID) face elevated risks of hospitalizations and readmissions due to serious injection-related infections, yet few evidence-based interventions exist to prevent readmissions. This stu...
Skylar Gross,Theodoros Giannouchos,Angela Rogers et al. Skylar Gross et al.
Objectives: This study assesses treatment initiation and retention among South Carolina Medicaid enrollees newly diagnosed with opioid use disorder in 2021, situating these outcomes within the broader opioid treatment cas...
Max Spaderna,Cecilia Bergeria Max Spaderna
Since 2000, the suicide rate from opioid overdoses has more than doubled, and the number of self-reported intentional opioid overdoses is likely undercounted. This commentary discusses how a sensitive and validated assessment is crucially n...
Gregory T Woods,Hannah Shadowen,Caroline Shadowen et al. Gregory T Woods et al.
Objectives: Buprenorphine is a partial opioid agonist used in the treatment of opioid use disorder. Dosing of buprenorphine is determined clinically, with peripartum adjustments often indicated due to physiological and ps...
Madeline B Benz,Michael D Stein,Camille Clifford et al. Madeline B Benz et al.
Despite a recent decline in overdose deaths, the United States continues to have the highest global overdose mortality rate. Polysubstance use-taking opioids along with other drugs-has been increasingly recognized as a key contributor to pr...
Sarah Kawasaki,Erik Lehman,Lan Kong et al. Sarah Kawasaki et al.
Objectives: This study evaluated ReSET-O, a mobile app derived from the previously studied, computer-based therapeutic education system (TES), delivering cognitive behavioral therapy (CBT) lessons plus contingency managem...
Payel Jhoom Roy,Nalingna Yuan,Yaming Li et al. Payel Jhoom Roy et al.
Objectives: In 2022, the FDA issued a drug safety communication based on case studies that transmucosal buprenorphine, a medication for opioid use disorder (MOUD), may contribute to dental disease. We sought to assess lon...
James R Langabeer,Andrea J Yatsco,Cohen A Sarah et al. James R Langabeer et al.
Objectives: Treatment for opioid use disorder (OUD) is constrained by financial and geographic barriers. Community-based approaches may help address these challenges, yet evidence regarding their sustained impact on treat...